Cholinesterase inhibitors – donepezil, rivastigmine and galantamine are approved medications for the treatment of dementia due to AD (Dou et al., 2018), and outcomes have so far produced modest benefits (Li et al., 2019). This evidence concerns the gene BCHE and Alzheimer disease.